Julie Galsgaard

Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease

Steffen Bank, Paal Skytt Andersen, Johan Burisch et al. · The Pharmacogenomics Journal · 2014 · 144 citations · Full text

Polymorphisms in the Inflammatory Pathway Genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG Are Associated with Susceptibility of Inflammatory Bowel Disease in a Danish Cohort

Steffen Bank, Paal Skytt Andersen, Johan Burisch et al. · PLoS ONE · 2014 · 125 citations · Full text

Polymorphisms in the <scp>NF</scp>kB, <scp>TNF</scp>‐alpha, <scp>IL</scp>‐1beta, and <scp>IL</scp>‐18 pathways are associated with response to anti‐<scp>TNF</scp> therapy in Danish patients with inflammatory bowel disease

Steffen Bank, Mette Julsgaard, Osama Karim Abed et al. · Alimentary Pharmacology & Therapeutics · 2019 · 76 citations · Full text

Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy

Steffen Bank, Paal Skytt Andersen, Johan Burisch et al. · The Pharmacogenomics Journal · 2017 · 64 citations

Inflammation, Chronic Inflammatory Diseases, Anti-tnf Therapy +9

Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy

Julie Galsgaard, Frederik Persson, Tine W. Hansen et al. · Kidney International · 2017 · 29 citations · Full text

All-cause Mortality, Type 1, Renal Function +10